Sign Up
OverviewAPI
The global oncology drugs market is set to reach $474.06 billion by 2030, driven by a strong CAGR of 11.53%. Factors such as the increasing cancer cases, treatment advancements, and higher tobacco consumption contribute to this growth. Major pharmaceutical companies are focusing on R&D and engaging in significant mergers and acquisitions. Targeted therapy and injectables are prevalent in the market, with North America leading due to high cancer rates and advanced healthcare facilities.

Ask a question